Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Dry distillation of astatine-211 by electromagnetic induction

Paul Martorano, Paul Martorano, Tahereh Taghvaee, David Schaub, Lawrence Toto, Hsiaoju Lee, Mehran MaKvandi and Robert Mach
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 518;
Paul Martorano
1University of Pennsylvania Health System Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Martorano
1University of Pennsylvania Health System Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tahereh Taghvaee
2University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Schaub
1University of Pennsylvania Health System Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence Toto
1University of Pennsylvania Health System Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsiaoju Lee
2University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehran MaKvandi
2University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Mach
2University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

518

Introduction: Astatine-211 (211At) is a promising alpha-emitter with properties that are well suited for targeted alpha-particle therapy; due to its short half-life of 7.2h it is typically produced on-site using bismuth-209 (209Bi) targets. Isolation of 211At from the 209Bi target is generally done in one of two ways, either by dry distillation or wet distillation. Dry distillation involves heating the target to 650°C and trapping the volatilized 211At, whereas, wet distillation is completed by dissolving the target in concentrated acid and then isolating the 211At via liquid-liquid extraction. Dry distillations are less operator intensive and take less time to perform compared to wet distillation (10-20min vs. 2h) with the drawbacks of lower recovery (50-75% vs 80-100%) and inconsistency. To improve the dry distillation process, we utilized electromagnetic induction in place of a conduction heater to rapidly heat the target. Induction operates using an alternating magnetic field to generate electric currents within the material (eddy currents). The resistance of the material generates heat from the currents - heating the target directly, rapidly, and without the need for external contact. In this work, we demonstrate the use of induction heating in place of traditional tube furnaces for the dry distillation of 211At.

Methods: Astatine-211 was produced on a JSW BC3015 cyclotron - via the nuclear reaction 209Bi(α,2n)211At - by irradiating elemental bismuth targets with aluminum backings with a 7µA beam of alpha-particles at 29MeV. Coin targets are composed of a thin layer of 209Bi (approximately 150mg) located in a shallow cavity milled into a larger aluminum body which makes up the majority of the target. The distillation setup consists of a quartz glass tube placed within the coils of an induction heater and connected to a solvent trap. The induction heater utilizes 48 volts and 18A of current passed through a 9 AWG copper solenoid coil (100mm in length, 8 turns) to generate the alternating magnetic field. During distillation, the target is placed in the quartz tube and within the coil. A vacuum pump pulls ambient air through the tube and the target is heated. Current is induced within the aluminum backing of the target due to its paramagnetic properties - bismuth metal is diamagnetic, making it a poor inductor - generating heat that transfers to the bismuth via conduction.

Results: Accurate temperature measurements are difficult to acquire as thermocouples induce heat and infrared measurements are distorted by the quartz tube. Astatine-211 begins to accumulate in the solvent trap after 30 seconds (boiling point of 337°C) and the aluminum can be observed melting after 90 seconds (melting point of 660°C). Distillations using the induction heater achieve an average recovery of 51% in 10 minutes. The coils of the induction heater reach a maximum temperature of 250°C during distillation and once completed, the entire system, including the target, cool to room temperature in 5 minutes. In comparison, the tube furnace reaches its target temperature of 750°C after 10-15 minutes. The tube furnace also yields a 51% recovery. However, the distillation requires 20 minutes and takes over 30 minutes to return to safe temperatures. Overall, the induction heater reduces the time required for 211At distillations while being less hazardous and maintaining similar recovery rates.

Conclusions: This study provides proof of concept for induction heating as a useful technique for the isolation of 211At. Induction heating is a viable replacement for standard conduction heating methods used in dry distillations of 211At. Furthermore, the technology has the potential for better dry distillation setups that would not be possible using standard tube furnaces allowing for better recoveries of 211At. Additional Data:

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dry distillation of astatine-211 by electromagnetic induction
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Dry distillation of astatine-211 by electromagnetic induction
Paul Martorano, Paul Martorano, Tahereh Taghvaee, David Schaub, Lawrence Toto, Hsiaoju Lee, Mehran MaKvandi, Robert Mach
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 518;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dry distillation of astatine-211 by electromagnetic induction
Paul Martorano, Paul Martorano, Tahereh Taghvaee, David Schaub, Lawrence Toto, Hsiaoju Lee, Mehran MaKvandi, Robert Mach
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 518;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
  • A Unique 18F-labeled G-protein-coupled receptor 44 (GPR44) radiotracer: design, radio-synthesis and evaluation in the rodents
  • 18F-Radiofluorination of Aryl C-H Bonds using a Tandem Ir C-H Borylation/Cu Radiofluorination Strategy
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Automation & Process Development

  • Semi-automatic radiolabeling of insulin-like growth factor-1 protein for the verification of its nose-to-brain delivery by positron emission tomography imaging.
  • Three New Fully Automated [11C]Carbonylation Chemistry Platforms for Radiopharmaceutical Production via [11C]CO2 and [11C]CO.
  • Fully automated one-pot radiosynthesis and dosimetry estimation for (R)-[18F]MeFAMP, a system A amino acid transport imaging agent
Show more Automation & Process Development

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire